Glenmark Pharmaceuticals - News
NSE: GLENMARK | BSE: 532296
₹2,210.20
As on 19-Oct-2026IST
Market cap
₹62,339 Cr
Revenue (TTM)
₹17,737 Cr
P/E Ratio
34.7
P/B Ratio
5.7
Div. Yield
0.1 %
Quarterly Updates
Annual Reports
NSE: GLENMARK | BSE: 532296
₹2,210.20
As on 19-Oct-2026IST
Market cap
₹62,339 Cr
Revenue (TTM)
₹17,737 Cr
P/E Ratio
34.7
P/B Ratio
5.7
Div. Yield
0.1 %
Annual Reports